Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, positio[...]
Read more
Articles written by Vandana Singh
AstraZeneca’s Drug Shows Promise For Resistant Hypertension In Phase 3 Trial
AstraZeneca Plc (NASDAQ:AZN) on Monday released topline data from the BaxHTN Phase 3 trial of baxdrostat in patients with uncontrolled or treatment-resistant hypertension. The trial included patients[...]
Read more